HRP20040324A2 - Novel substituted 4-fenil-4-[1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists - Google Patents

Novel substituted 4-fenil-4-[1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists

Info

Publication number
HRP20040324A2
HRP20040324A2 HR20040324A HRP20040324A HRP20040324A2 HR P20040324 A2 HRP20040324 A2 HR P20040324A2 HR 20040324 A HR20040324 A HR 20040324A HR P20040324 A HRP20040324 A HR P20040324A HR P20040324 A2 HRP20040324 A2 HR P20040324A2
Authority
HR
Croatia
Prior art keywords
fenil
imidazol
piperidine derivatives
novel substituted
opioid agonists
Prior art date
Application number
HR20040324A
Other languages
English (en)
Inventor
Eduard Janssens Frans
Elisabeth Leenaerts Joseph
Francisco
Gomez-Sanchez Antonio
Frans Meert Theo
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of HRP20040324A2 publication Critical patent/HRP20040324A2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
HR20040324A 2001-10-15 2004-04-06 Novel substituted 4-fenil-4-[1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists HRP20040324A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01203926 2001-10-15
PCT/EP2002/011372 WO2003033486A1 (en) 2001-10-15 2002-10-10 Novel substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists

Publications (1)

Publication Number Publication Date
HRP20040324A2 true HRP20040324A2 (en) 2005-04-30

Family

ID=8181080

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20040324A HRP20040324A2 (en) 2001-10-15 2004-04-06 Novel substituted 4-fenil-4-[1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists

Country Status (26)

Country Link
US (2) US7282508B2 (de)
EP (1) EP1438304B1 (de)
JP (1) JP4417108B2 (de)
KR (1) KR100898562B1 (de)
CN (1) CN100354273C (de)
AR (1) AR037506A1 (de)
AT (1) ATE347549T1 (de)
AU (1) AU2002346994B2 (de)
BR (1) BR0213327A (de)
CA (1) CA2462953C (de)
CY (1) CY1106356T1 (de)
DE (1) DE60216627T2 (de)
EA (1) EA006507B1 (de)
ES (1) ES2278065T3 (de)
HR (1) HRP20040324A2 (de)
HU (1) HUP0600447A3 (de)
IL (2) IL161348A0 (de)
MX (1) MXPA04003479A (de)
MY (1) MY137356A (de)
NO (1) NO327602B1 (de)
NZ (1) NZ531679A (de)
PL (1) PL367967A1 (de)
PT (1) PT1438304E (de)
UA (1) UA76224C2 (de)
WO (1) WO2003033486A1 (de)
ZA (1) ZA200402818B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002363369B2 (en) * 2001-10-15 2008-08-21 Janssen Pharmaceutica N.V. Substituted 4-phenyl-4-(1H-imidazol-2-yl)-piperidine derivatives for reducing ischaemic damage
TW200403058A (en) * 2002-04-19 2004-03-01 Bristol Myers Squibb Co Heterocyclo inhibitors of potassium channel function
JP2006515278A (ja) * 2002-05-08 2006-05-25 ニューロジェン コーポレイション 置換イミダゾリルメチルピリジン及びピラジン誘導体並びにそれらのｇａｂａａ受容体リガンドとしての使用
US20060128752A1 (en) * 2002-07-03 2006-06-15 Giuseppe Alvaro Chemical compounds
AR044010A1 (es) * 2003-04-11 2005-08-24 Janssen Pharmaceutica Nv Uso de derivados de 4-fenil-4- [1h-imidazol-2-il]- piperidina sustituidos como agonistas delta opioideos no peptidos selectivos, con actividad antidepresiva y ansiolitica
BRPI0415165A (pt) 2003-10-01 2007-01-09 Adolor Corp composto heterocìclico espirocìclico, composição farmacêutica, método para ligar receptores opióides, métodos para prevenir ou tratar dor, disfunção gastrointestinal, um distúrbio do trato urogenital, um distúrbio imunomodulatório, um distúrbio inflamatório, um distúrbio de função respiratória, ansiedade, distúrbio do humor, um distúrbio relacionado a estresse, distúrbio do sistema nervoso simpático, tosse, e um distúrbio motor, método para tratar uma lesão traumática ao sistema nervoso central, métodos para prevenir ou tratar acidente vascular, arritmia cardìaca, glaucoma, e disfunção sexual, métodos para tratar uma condição selecionada do grupo consistindo de choque, edema cerebral, isquemia cerebral, déficit cerebral após cirurgia cardìaca (bypass) e enxerto, lupus eritematoso sistêmico, doença de hodgkin, doença de sjogren, epilepsia, e rejeição em transplantes de órgão e enxertos de pele, e para tratar dependência de substáncias, métodos para melhorar a sobrevivência de órgãos e células, e cardioproteção após infarto do miocárdio, métodos para reduzir a necessidade de anestesia, para produzir ou manter um estado anestésico, derivado radiomarcado de um composto, derivado isotopicamente marcado de um composto, composto e método de diagnóstico por imagem
SI1725537T1 (sl) 2004-03-15 2011-11-30 Janssen Pharmaceutica Nv Nove spojine kot modulatorji opioidnih receptorjev
AU2013205089B2 (en) * 2004-03-15 2013-12-19 Janssen Pharmaceutica, N.V. Novel compounds as opioid receptor modulators
US7598261B2 (en) 2005-03-31 2009-10-06 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
US7576207B2 (en) 2006-04-06 2009-08-18 Adolor Corporation Spirocyclic heterocyclic derivatives and methods of their use
EP2063886A2 (de) 2006-09-12 2009-06-03 Adolor Corporation Verwendung von stickstoff-haltigen spiroverbindungen zur steigerung kognitiver funktionen
IT1396951B1 (it) * 2009-12-18 2012-12-20 Neuroscienze Pharmaness S C A R L Composti farmaceutici
US9675587B2 (en) 2013-03-14 2017-06-13 Allergan Holdings Unlimited Company Opioid receptor modulator dosage formulations
TWI652264B (zh) * 2013-09-26 2019-03-01 東麗股份有限公司 Cyclic amine derivatives and their medical uses
JP7450534B2 (ja) 2017-10-19 2024-03-15 帝人ファーマ株式会社 ベンズイミダゾール誘導体及びその用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2985322B2 (ja) 1991-03-01 1999-11-29 東レ株式会社 イソキノリン誘導体およびその医薬用途
US5354863A (en) * 1992-01-21 1994-10-11 G. D. Searle & Co. Opioid agonist compounds
GB9202238D0 (en) 1992-02-03 1992-03-18 Wellcome Found Compounds
US5731322A (en) 1993-08-06 1998-03-24 Smithkline Beecham S.P.A. Octahydro-1H-pyrrolo 3,2-g!and 2,3-g!isoquinoline derivatives
US5618934A (en) 1994-05-17 1997-04-08 Merck & Co., Inc. Boronic acid compound
WO1996022276A1 (fr) 1995-01-20 1996-07-25 Nippon Shinyaku Co., Ltd. Derives d'ethylamine et medicaments
IT1307327B1 (it) 1995-09-12 2001-10-30 Smithkline Beecham Spa Derivati idroisochinolinici sostituiti
SE9604786D0 (sv) 1996-12-20 1996-12-20 Astra Pharma Inc New compounds
TW548271B (en) 1996-12-20 2003-08-21 Astra Pharma Inc Novel piperidine derivatives having an exocyclic double bond with analgesic effects
DE19805370A1 (de) 1997-03-14 1998-09-17 Gruenenthal Gmbh Substituierte Aminoverbindungen und ihre Verwendung als analgetisch wirksame Substanzen
GB9709972D0 (en) 1997-05-19 1997-07-09 Pfizer Ltd Tetrazoles
AU764820C (en) 1998-12-19 2004-11-18 Janssen Pharmaceutica N.V. Antihistaminic spiro compounds
EP1038872A1 (de) 1999-02-22 2000-09-27 Pfizer Products Inc. 4-Phenyl-4-heteroarylpiperdine Derivate als Opioid-Rezeptorligande
JP2005231995A (ja) 1999-12-22 2005-09-02 Meiji Seika Kaisha Ltd オピオイドδ受容体アゴニスト／アンタゴニストとして有用なスピロ化合物

Also Published As

Publication number Publication date
JP4417108B2 (ja) 2010-02-17
NZ531679A (en) 2005-02-25
AU2002346994B2 (en) 2007-09-06
MY137356A (en) 2009-01-30
KR100898562B1 (ko) 2009-05-20
NO327602B1 (no) 2009-08-31
US20080096925A1 (en) 2008-04-24
CA2462953C (en) 2011-01-04
CN100354273C (zh) 2007-12-12
EP1438304A1 (de) 2004-07-21
UA76224C2 (en) 2006-07-17
US20040260096A1 (en) 2004-12-23
PT1438304E (pt) 2007-03-30
KR20050035121A (ko) 2005-04-15
DE60216627D1 (de) 2007-01-18
HUP0600447A3 (en) 2008-03-28
IL161348A (en) 2010-11-30
AR037506A1 (es) 2004-11-17
NO20041666L (no) 2004-04-22
US7282508B2 (en) 2007-10-16
JP2005505625A (ja) 2005-02-24
PL367967A1 (en) 2005-03-07
ATE347549T1 (de) 2006-12-15
EA200400545A1 (ru) 2004-08-26
EP1438304B1 (de) 2006-12-06
ZA200402818B (en) 2005-06-29
BR0213327A (pt) 2004-10-13
CA2462953A1 (en) 2003-04-24
HUP0600447A2 (en) 2006-09-28
CN1568321A (zh) 2005-01-19
MXPA04003479A (es) 2004-07-30
ES2278065T3 (es) 2007-08-01
WO2003033486A1 (en) 2003-04-24
CY1106356T1 (el) 2011-10-12
DE60216627T2 (de) 2007-09-20
EA006507B1 (ru) 2005-12-29
IL161348A0 (en) 2004-09-27

Similar Documents

Publication Publication Date Title
AU4274401A (en) Diphenylalkylamine derivatives useful as opioid delta receptor agonists
IL159697A0 (en) Substituted anilinic piperidines as mch selective antagonists
ZA200402818B (en) Novel substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists
DK1244447T3 (da) Nye fremgangsmåder og sammensætninger indeholdende opioider og deres antagonister
HK1061854A1 (en) Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
IL160693A0 (en) Lactam-containing compounds and derivatives thereof as factor xa inhibitors
NO20023729D0 (no) Preparater med regulert frigivelse inneholdende opioidagonist og -antagonist
AU7392101A (en) 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors
IL160060A0 (en) Piperidine derivatives useful as ccr5 antagonists
AU2002361861A8 (en) Selective 11beta-hsd inhibitors and methods for use thereof
GB0108099D0 (en) Aminopiperidine derivatives
IL154343A0 (en) Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors
HK1072562A1 (en) Substituted 4-phenyl-4-(1H-imidazol-2-yl)-piperidine derivatives for reducing ischaemic damage
IL159538A0 (en) 8/17 heterocyclic compounds and uses thereof as d-alanyl-d-alanine ligase inhibitors
EP1585519A4 (de) Hochkonzentrierte formulierungen vonopioiden und opiod-derivaten
PL1663971T3 (pl) Podstawione 2-karbonyloamino-6-piperydynoaminopirydyny oraz podstawione 1-karbonyloamino-3-piperydynoaminobenzeny jako agoniści 5-ht1f
IL158056A0 (en) Chemical derivatives and their use as anti-telomerase agent
IL162443A0 (en) Imidazoquinoline derivatives
IL162378A0 (en) 3-Phenyl-2-arylalkylthiopropionic acid derivativesas selective agonists of ppar-al-pha
AU2001271018A1 (en) Gpr14 antagonist
IL150862A0 (en) Heterocyclic amide derivatives
IL142810A0 (en) Pharmaceutical uses for fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
GB0203197D0 (en) Delta opioid agonists
IL156794A0 (en) Chemical derivatives and their use as anti-telomerase agent
AU2002229859A1 (en) Chemical derivatives and their use as anti-telomerase agent

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20101006

Year of fee payment: 9

OBST Application withdrawn